Boix Roger, Sanz Carolina, Mora Miguel, Quer Ariadna, Beyer Katrin, Musulen Eva, González Carlos, Bayona Salvador, Saladié Josep M, Ariza Aurelio
Department of Urology, Germans Trias i Pujol University Hospital, Badalona, Spain.
Transplantation. 2009 Apr 15;87(7):1057-61. doi: 10.1097/TP.0b013e31819d1e5f.
Primary renal cell carcinoma (RCC) is the most frequent kidney cancer. In renal transplant patients, RCC more commonly arise in the native kidneys, whereas allograft involvement has been just occasionally reported. In these latter cases, a graft origin of tumor cells should be considered and other recipients from the same donor should be investigated. So far, genetic studies to trace the origin of cancer cells have always confirmed the donor origin of these tumors.
A 58-year-old man developed an RCC in the grafted kidney 14 years after transplantation. Histologic and immunohistochemical studies diagnosed a clear cell RCC with sarcomatoid changes. A nine microsatellite DNA assay was used to compare renal tumor cells with donor's (graft parenchyma) and recipient's (lymph nodes and blood) cells.
Of the nine microsatellites analyzed, four turned out to be noninformative and the other five (D1S2734, D1S214, D1S199, D19S219, and Humara) showed different band profiles in donor's and recipient's cells DNA. Tumor and blood profile matching confirmed the recipient origin of neoplastic cells.
We report the first case of a grafted-kidney RCC whose recipient's cell origin has been proved by microsatellite analysis. An origin from the recipient's kidney or bone marrow stem cells is proposed as the more plausible hypothesis.
原发性肾细胞癌(RCC)是最常见的肾癌。在肾移植患者中,RCC更常见于原生肾,而异体肾受累情况仅有偶尔报道。在这些病例中,应考虑肿瘤细胞的移植物起源,并对来自同一供体的其他受者进行调查。到目前为止,追踪癌细胞起源的基因研究一直证实这些肿瘤起源于供体。
一名58岁男性在肾移植14年后移植肾发生RCC。组织学和免疫组化研究诊断为伴有肉瘤样改变的透明细胞RCC。采用九微卫星DNA分析方法,将肾肿瘤细胞与供体(移植肾实质)和受体(淋巴结和血液)细胞进行比较。
在分析的九个微卫星中,四个无信息价值,另外五个(D1S2734、D1S214、D1S199、D19S219和Humara)在供体和受体细胞DNA中显示出不同的条带图谱。肿瘤与血液图谱匹配证实肿瘤细胞起源于受体。
我们报告首例通过微卫星分析证实肿瘤细胞起源于受体的移植肾RCC病例。提出肿瘤起源于受体肾脏或骨髓干细胞这一更合理的假说。